Serum tumour M2‐pyruvate kinase as a biomarker for diagnosis and prognosis of early‐stage non–small cell lung cancer

Tumour M2‐pyruvate kinase (TUM2‐PK) is up‐regulated in many human cancers. This study was to evaluate the clinical value of serum TUM2‐PK in early‐stage non–small cell lung cancer (NSCLC) patients. A total of 162 consecutive early‐stage NSCLC patients were enrolled and followed up after tumour resec...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chunhua, Liu, Wei, Li, Li, Wang, Yuchao, Yuan, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335667/
https://www.ncbi.nlm.nih.gov/pubmed/34255923
http://dx.doi.org/10.1111/jcmm.16762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335667/
https://www.ncbi.nlm.nih.gov/pubmed/34255923
http://dx.doi.org/10.1111/jcmm.16762

Ejemplares similares